|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current assets | |||||||||
| Cash | |||||||||
| Prepaid expenses | |||||||||
| Deferred offering costs | |||||||||
| Marketable securities held in Trust Account-current | |||||||||
| Total current assets | |||||||||
| Marketable securities held in Trust Account | |||||||||
| Total current assets | |||||||||
| TOTAL ASSETS | |||||||||
| Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity | |||||||||
| Current liabilities | |||||||||
| Accounts payable and accrued expenses | |||||||||
| Due to a related party | |||||||||
| Promissory note - a related party | |||||||||
| Total current liabilities | |||||||||
| Total Liabilities | |||||||||
| Ordinary shares subject to possible redemption, 3,879,970 and 5,750,000 shares subject to possible redemption at September 30, 2026 and December 31, 2025, respectively | |||||||||
| Shareholders’ (Deficit) Equity: | |||||||||
| Ordinary shares, $0.0001 par value, 500,000,000 shares authorized, 1,794,000 shares issued and outstanding (excluding 3,879,970 and 5,750,000 shares subject to redemption) at September 30, 2026 and December 31, 2025, respectively | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| Total Shareholders’ (Deficit) Equity | |||||||||
| TOTAL LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ (DEFICIT) EQUITY |
Loading...